The BNF is a joint publication of the British Medical
Association and the Royal Pharmaceutical Society. It ispublished under the authority of a Joint Formulary
Committee which comprises representatives of the
two professional bodies, the UK Health Departments,
the Medicines and Healthcare products Regulatory
Agency, and a national guideline producer. The Dental
Advisory Group oversees the preparation of advice on
the drug management of dental and oral conditions; the
Group includes representatives of the British Dental
Association and a representative from the UK Health
Departments. The Nurse Prescribers’ Advisory Group
advises on the content relevant to nurses and includes
representatives from different parts of the nursing community
and from the UK Health Departments.
The BNF aims to provide prescribers, pharmacists, and
other healthcare professionals with sound up-to-date
information about the use of medicines.
The BNF includes key information on the selection,
prescribing, dispensing and administration of medicines.
Medicines generally prescribed in the UK are
covered and those considered less suitable for prescribing
are clearly identified. Little or no information
is included on medicines promoted for purchase by the
public.
Information on drugs is drawn from the manufacturers’
product literature, medical and pharmaceutical literature,
UK health departments, regulatory authorities, and
professional bodies. Advice is constructed from clinical
literature and reflects, as far as possible, an evaluation of
the evidence from diverse sources. The BNF also takes
account of authoritative national guidelines and emerging
safety concerns. In addition, the editorial team
receives advice on all therapeutic areas from expert
clinicians; this ensures that the BNF’s recommendations
are relevant to practice…
0 comments:
Post a Comment